The Post-Vitrectomy Lenstatin™ Study

Completed · Not applicable · Has a placebo group

Conditions studied: Cataract, Nuclear Progressive

In brief

To determine the efficacy of Lenstatin™, an over-the-counter nutritional supplement, in inhibiting the progression of nuclear cataract in eyes after pars plana vitrectomy.

Key facts

Study ID

NCT02131194

Run by

Lenstatin LLC

People needed

20

Starts

2014-06-01

Expected to finish

2015-12-01

Last updated by the study team

2015-12-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults over the age of 18
• Post pars plana vitrectomy surgery

You may not qualify if…

• Pediatric patients under the age of 18
• Pregnant women
• Hypersensitivity to any of the ingredients in Lenstatin

Where it is running

• Scott W. Tunis MD FACS — Wilmington, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.